148
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Non-Adherence To Childhood HPV Vaccination Is Associated With Non-Participation In Cervical Cancer Screening A Nationwide Danish Register-Based Cohort Study

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 969-980 | Published online: 08 Nov 2019

References

  • Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. PMC3681632; Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013;2:35. doi:10.1186/2046-4053-2-3523706117
  • Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer. 2009;45(15):2640–2648. doi:10.1016/j.ejca.2009.07.01819695864
  • Arbyn M, Xu L, Simoens C, Martin-Hirsch P. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018;5:CD009069. doi:10.1002/14651858.CD009069.pub329740819
  • European Medicines Agency. Summary of the European Public Assessment Report (EPAR) for Cervarix. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000721/human_med_000694.jsp&mid=WC0b01ac058001d124 Accessed 628, 2019.
  • European Medicines Agency. Summary of the European Public Assessment Report (EPAR) for Gardasil. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000703/human_med_000805.jsp Accessed 628, 2019.
  • Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:9590; ProQuest pg. 890. doi:10.1016/S0140-6736(07)61416-0
  • World Health Organization. Countries with HPV Vaccine in the National Immunization Programme. Available from: https://www.who.int/immunization/diseases/hpv/decision_implementation/en/ Accessed 628, 2019.
  • Statens Serum Institut. Available from: http://www.ssi.dk/~/media/Indhold/DK%20-%20dansk/Aktuelt/Nyhedsbreve/EPI-. NYT/2008/2008%20PDF/EPI-NYT%20-%202008%20-%20uge%2035.ashx Accessed 628, 2019
  • Azerkan F, Sparen P, Sandin S, Tillgren P, Faxelid E, Zendehdel K. Cervical screening participation and risk among Swedish-born and immigrant women in Sweden. Int J Cancer. 2012;130(4):937–947. doi:10.1002/ijc.2608421437898
  • Slattelid Schreiber SM, Juul KE, Dehlendorff C, Kjaer SK. Socioeconomic predictors of human papillomavirus vaccination among girls in the Danish childhood immunization program. J Adolesc Health. 2015;56(4):402–407. doi:10.1016/j.jadohealth.2014.12.00825659994
  • Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K, Hickman M. Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Int J Epidemiol. 2013;42(3):896–908. doi:10.1093/ije/dyt04923620381
  • Agenor M, Abboud S, Delgadillo JG, Perez AE, Peitzmeier SM, Borrero S. Intersectional nativity and racial/ethnic disparities in human papillomavirus vaccination initiation among U.S. women: a national population-based study. Cancer Causes Control. 2018;29(10):927–936. doi:10.1007/s10552-018-1069-130120642
  • Perez AE, Agenor M, Gamarel KE, Operario D. Nativity disparities in human papillomavirus vaccination among U.S. adults. Am J Prev Med. 2018;54(2):248–258. S0749-3797(17)30642-6 [pii]. doi:10.1016/j.amepre.2017.10.019.29241719
  • Cofie LE, Hirth JM, Guo F, Berenson AB, Markides K, Wong R. HPV vaccination among foreign-born women: examining the national health interview survey 2013-2015. Am J Prev Med. 2018;54(1):20–27. S0749-3797(17)30458-0 [pii]. doi:10.1016/j.amepre.2017.08.017.29074320
  • Widgren K, Simonsen J, Valentiner-Branth P, Molbak K. Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark. Vaccine. 2011;29(52):9663. doi:10.1016/j.vaccine.2011.10.02122015392
  • Fernandez de Casadevante V, Gil Cuesta J, Cantarero-Arevalo L. Determinants in the uptake of the human papillomavirus vaccine: a systematic review based on european studies. Front Oncol. 2015;5:141. doi:10.3389/fonc.2015.0014126157706
  • Fernandez de Casadevante V, Cantarero-Arevalo L, Cuesta JG, Valentiner-Branth P .Ethnic background and human papillomavirus vaccine uptake in Denmark: a countrywide retrospective cohort study including 274,154 women aged 19-28 years. Papillomavirus Res.2016;2:78–84. S2405-8521(15)30010-0 [pii]. doi:10.1016/j.pvr.2016.03.003.29074189
  • Roberts SA, Brabin L, Stretch R, et al. Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiol Infect. 2011;139(3):400–405. doi:10.1017/S095026881000066X20334731
  • Kristensson JH, Sander BB, von Euler-Chelpin M, Lynge E. Predictors of non-participation in cervical screening in Denmark. Cancer Epidemiol. 2014;38(2):174. doi:10.1016/j.canep.2013.12.00724447699
  • Harder E, Juul KE, Jensen SM, Thomsen LT, Frederiksen K, Kjaer SK. Factors associated with non-participation in cervical cancer screening – a nationwide study of nearly half a million women in Denmark. Prev Med. 2018;111:94–100. doi:10.1016/j.ypmed.2018.02.03529501474
  • Broberg G, Wang J, Ostberg AL, et al. Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: a population-based case-control study. PLoS One. 2018;13(1):e0190171. doi:10.1371/journal.pone.019017129320536
  • Moen KA, Kumar B, Qureshi S, Diaz E. Differences in cervical cancer screening between immigrants and nonimmigrants in Norway: a primary healthcare register-based study. Eur J Cancer Prev. 2017;26(6):521–527. doi:10.1097/CEJ.000000000000031127749381
  • Leinonen MK, Campbell S, Ursin G, Trope A, Nygard M. Barriers to cervical cancer screening faced by immigrants: a registry-based study of 1.4 million women in Norway. Eur J Public Health. 2017;27(5):873–879. doi:10.1093/eurpub/ckx09328957477
  • Kreusch T, Wang J, Sparen P, Sundstrom K. Opportunistic HPV vaccination at age 16–23 and cervical screening attendance in Sweden: a national register-based cohort study. BMJ Open. 2018;8(10):e024477-2018-024477. doi:10.1136/bmjopen-2018-024477
  • Boone SD, Pinkston CM, Baumgartner KB, et al. Associations between prior HPV4 vaccine doses and cervical cancer screening participation. Cancer Epidemiol. 2016;42:108–114. doi:10.1016/j.canep.2016.04.00327100836
  • Palmer TJ, McFadden M, Pollock KG, et al. HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data. Br J Cancer. 2016;114(5):576–581. doi:10.1038/bjc.2015.47326794278
  • Chao C, Silverberg MJ, Becerra TA, et al. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system. Am J Obstet Gynecol. 2017;216(2):151.e1-151.e9 S0002-9378(16)30869-9 [pii]. doi:10.1016/j.ajog.2016.10.006.
  • Kim J, Bell C, Sun M, et al. Effect of human papillomavirus vaccination on cervical cancer screening in Alberta. CMAJ. 2016;188(12):E281–E288. doi:10.1503/cmaj.15152827378467
  • Herweijer E, Feldman AL, Ploner A, et al. The participation of HPV-vaccinated women in a national cervical screening program: population-based cohort study. PLoS One. 2015;10(7):e0134185. doi:10.1371/journal.pone.013418526218492
  • Paynter CA, Van Treeck BJ, Verdenius I, et al. Adherence to cervical cancer screening varies by human papillomavirus vaccination status in a high-risk population. Prev Med Rep. 2015;2:711–716. doi:10.1016/j.pmedr.2015.07.01126844141
  • Sauer AG, Jemal A, Simard EP, Fedewa SA. Differential uptake of recent papanicolaou testing by HPV vaccination status among young women in the United States, 2008–2013. Cancer Epidemiol. 2015;39(4):650–655. doi:10.1016/j.canep.2015.05.00226055147
  • Kliewer EV, Mahmud SM, Demers AA, Lambert P. Human papillomavirus vaccination and pap testing profile in Manitoba, Canada. Vaccine. 2013;32(1):33–38. doi:10.1016/j.vaccine.2013.10.08224211170
  • Beer H, Hibbitts S, Brophy S, Rahman MA, Waller J, Paranjothy S. Does the HPV vaccination programme have implications for cervical screening programmes in the UK? Vaccine. 2014;32(16):1828–1833. doi:10.1016/j.vaccine.2014.01.08724530938
  • Budd AC, Brotherton JM, Gertig DM, Chau T, Drennan KT, Saville M. Cervical screening rates for women vaccinated against human papillomavirus. Med J Aust. 2014;201(5):279–282. 10.5694/mja14.00021[pii]. doi:10.5694/mja14.00021.25163380
  • Statistics Denmark. Population. Available from: https://www.dst.dk/da/Statistik/emner/befolkning-og-valg/befolkning-og-befolkningsfremskrivning/folketal Accessed 628, 2019.
  • Bigaard J, Hariri J, Lynge E. Cervical cancer screening in Denmark. Eur J Cancer. 2000;36(17):2198 S0959-8049(00)00309-9 [pii]. doi:10.1016/s0959-8049(00)00174-x.11072204
  • The Danish Health and Medicines Authority. Reduction in the Risk of Cervical Cancer by Vaccination against Human Papillomavirus (HPV) – a Health Technology Assessment Copenhagen. 2007.
  • Pedersen CB. the danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22–25. doi:10.1177/140349481038796521775345
  • Andersen JS, Olivarius Nde F, Krasnik A. The Danish national health service register. Scand J Public Health. 2011;39(7):34–37. doi:10.1177/140349481039471821775348
  • Kildemoes HW, Sorensen HT, Hallas J. The Danish national prescription registry. Scand J Public Health. 2011;39(7 Suppl):38–41. doi:10.1177/140349481039471721775349
  • Bjerregaard B, Larsen OB. The Danish pathology register. Scand J Public Health. 2011;39(7 Suppl):72–74. doi:10.1177/140349481039356321775357
  • Côté RA. Progress in Medical Information Management Systematized Nomenclature of Medicine (SNOMED). Jama. 1980;243(8):756–762. doi:10.1001/jama.1980.033003400320156986000
  • Statistics Denmark. English Front Page. Available from: https://www.dst.dk/en Accessed 909, 2019
  • Galobardes B, Shaw M, Lawlor DA, Lynch JW, George DS. Indicators of socioeconomic position (part 1). 2006 0.1136/jech.2004.023531.
  • UNESCO. International Standard Classification of Education, ISCED. Quebec, Canada: UNESCO Institute for Statistics; 2011 Avaiable from: http://www.uis.unesco.org/Education/Documents/isced-2011-en.pdf Accessed 628, 2019.
  • OECD. Project on Income Distribution and Poverty. What are equivalence scales? Available from: http://www.oecd.org/els/soc/OECD-Note-EquivalenceScales.pdf Accessed 628, 2019
  • Bruni L, Diaz M, Barrionuevo-Rosas L, et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Global Health. 2016;4(7):e453–e463. doi:10.1016/s2214-109x(16)30099-727340003
  • Statens Serum Institut. HPV-Vaccination Coverage for Birth Cohorts 1993–2006. Available fom: https://statistik.ssi.dk//sygdomsdata#!/?vaccination=5&sex=0&landsdel=100&xaxis=Cohort&show=Graph&datatype=Vaccination Accessed 628, 2019
  • Statistics Denmark. Mothers Age at First Child Delivery. Available from: https://www.statistikbanken.dk/statbank5a/default.asp?w=1920 Accessed 909, 2019
  • Statistics Denmark. Mean Age at First Child Delivery. Avaialble from: https://www.statistikbanken.dk/statbank5a/default.asp?w=1920 Accessed 909, 2019.
  • World Health Organization. Overview of Global National HPV Vaccination and Cervical Cancer Screenings Programs. Available from: https://www.who.int/ Accessed 730, 2019.
  • Sancho-Garnier H, Khazraji YC, Cherif MH, et al. Overview of cervical cancer screening practices in the extended Middle East and North Africa countries. Vaccine. 2013;31(Suppl 6):G51. doi:10.1016/j.vaccine.2012.06.04624331820
  • Holt N, Mygind A, Bro F. Danish MMR Vaccination Coverage Is Considerably Higher than Reported. 2017.
  • Tranberg M, Larsen MB, Mikkelsen EM, Svanholm H, Andersen B. Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study. BMC Public Health. 2015;15:681. doi:10.1186/s12889-015-2039-026194007
  • Harder E, Thomsen LT, Hertzum-Larsen R, et al. Determinants for participation in human papillomavirus self-sampling among nonattenders to cervical cancer screening in denmark. Cancer Epidemiol Biomarkers Prev. 2018;27(11):1342–1351. doi:10.1158/1055-9965.EPI-18-048030108095
  • Marlow LAV, Waller J, Wardle J. Barriers to cervical cancer screening among ethnic minority women: a qualitative study. J Fam Plann Reprod Health Care. 2015;41(4):248–254. doi:10.1136/jfprhc-2014-10108225583124
  • Islam N. Understanding Barriers and Facilitators to Breast and Cervical Cancer Screening among Muslim Women in New York City – Perspectives from Key Informants. 2018.
  • Gele AA, Qureshi SA, Kour P, Kumar B, Diaz E. Barriers and facilitators to cervical cancer screening among Pakistani and Somali immigrant women in Oslo: a qualitative study. Int J Womens Health. 2017;9:487–496. doi:10.2147/IJWH.S13916028740435
  • Ghebre RG, Sewali B, Osman S, et al. Cervical cancer: barriers to screening in the Somali community in Minnesota. J Immigr Minor Health. 2015;17(3):722–728. doi:10.1007/s10903-014-0080-125073605
  • Ferdous M, Lee S, Goopy S, et al. Barriers to cervical cancer screening faced by immigrant women in Canada: a systematic scoping review. BMC Womens Health. 2018;18(1): 165-018-0654-5. doi:10.1186/s12905-018-0654-5
  • Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q. 1988;15(2):175–183.3378902